Exelixis Shares Rising on CABOMETYX Revenue
Big Money pushes Exelixis, Inc. (EXEL) shares higher by 149% since 2017.
Pharma & Biotech
Drug approvals, clinical trials, and news from the pharmaceutical and biotech industry.
McDonald's Unveils $8.5 Billion AI and Menu Overhaul
McDonald's wants AI to cut 50 labor hours a week
McDonald’s new AI system takes aim at a major restaurant cost
Lilly Weight-Loss Drugs Outperform Competitors
Lilly's retatrutide GLP-1 delivers average weight loss of 50 pounds
People with Type 2 diabetes lost an average of nearly 50 pounds on highest dose of Eli Lilly's GLP-1 medication retatrutide, the company said.
Viking Therapeutics Challenges Eli Lilly
Could This Mid-Cap GLP-1 Stock Be a Better Buy Than Eli Lilly?
Shares of Viking Therapeutics took off recently after the company released some promising data about its GLP-1 drug.
